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A 67-year-old man presented at our hospital with severe edema on the left side of his neck, chest and
brachial regions. He had a history of right radical nephrectomy due to renal cell carcinoma (RCC, clear cell
subtype, stage II) 15 years earlier. Thereafter, metastases to the pancreatic tail and right lung, and left lung
metastasis were removed at 8 years and 11 years, respectively, after the nephrectomy. Four years earlier, he
had also undergone total gastrectomy for gastric carcinoma (poorly differentiated adenocarcinoma, stage IV)
and subsequent maintenance chemotherapy for gastric carcinoma. Follow-up computed tomography (CT)
disclosed bilateral lung metastases and a pancreatic head metastasis. Cytology of pleural effusion on
admission suggested pleuritis carcinomatosa from RCC. Clinical diagnosis was bilateral lung and
pancreatic head metastases, pleuritis carcinomatosa and left subclavian vein thrombosis due to RCC
metastasis. Maintenance chemotherapy for gastric carcinoma was replaced by Sunitinib 50 mg for RCC
but he died of progressive disease 20 days later. Immunohistochemical study of the tissue from autopsy
revealed lung metastasis and pancreatic head metastasis from both RCC and gastric carcinoma as well as
multiple visceral metastases, pleuritis carcinomatosa and left subclavian vein thrombosis due to gastric
carcinoma. Cause of death was acute respiratory failure due to pulmonary tumor embolism and pulmonary
edema. Immunohistochemical study from autopsy was able to reveal the exact diagnosis, and
immunohistochemical studies may be helpful in diagnosing the exact origin of metastasis and selecting
appropriate treatments in patients with multiple cancers.
(Hinyokika Kiyo 62 : 473-477, 2016 DOI : 10.14989/ActaUrolJap_62_9_473)












* 現 : 公立甲賀病院泌尿器科
症 例
患 者 : 67歳，男性
既往歴 : 高血圧，盲腸癌（63歳時，回盲部切除術施
行．pTis pN0M0，p stage 0），肺動脈血栓症（65歳時，
胃癌術後に発症．抗凝固療法で軽快）













Fig. 1. Enhanced CT on admission shows A) left
pleural effusion (＊) and left subclavian vein
thrombosis (△). B) hypervascular lesion of
pancreatic head (arrow). C) lung metas-
tasis (arrow).
泌62,08,0◆-2
Fig. 2. Cytology of pleural effusion : atypical cells






M1（No 16），p stage IV であったため，術後より







現 症 : 左頸部，鎖骨下，前胸部および左上腕にか
けて発赤・腫脹あり
血液生化学検査 : Ht 35.4％，Hb 11.8 g/dl，WBC
4,400，Plt 252,000，D-D 27.9 μg/ml（＜0.9），CEA
4.2 ng/ml（＜5.0），CA19-9 12 U/ml（＜36），CA125
32 U/ml（＜34）と D-D の上昇を認めた．















療法に加えて sunitinib 50 mg を 4週間投与 2週間休薬
のプロトコールで開始した．






剖検所見 : 右肺上葉では CK7 陰性，E-cadherin 陰
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Fig. 3. Histopathological appearance shows lung metastases from both gastric carcinoma (white square) and RCC
(black square). A, B, C) immunohistochemical staining. RCC (▲) was negative for CK7 and E-
cadherin, and positive for vimentin. Gastric carcinoma (white circle) was positive for CK7 and E-
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Fig. 4. Histopathological appearance shows A) tumor embolism from gastric carcinoma in the vessels of both
lungs (white arrow), B) pancreatic head metastasis outside the capsule from gastric carcinoma (white
square), inside the capsule from RCC (black square), C) tumor embolism from gastric carcinoma in left
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